EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 34 / No 8-9 (Août–Septembre 2018) Med Sci (Paris), 34 8-9 (2018) 657-659 References
Free Access
Issue
Med Sci (Paris)
Volume 34, Number 8-9, Août–Septembre 2018
Les Cahiers de Myologie
Page(s) 657 - 659
Section Le Magazine
DOI https://doi.org/10.1051/medsci/20183408009
Published online 19 September 2018
  1. Marabelle A Routy B Michels J et al. Prime time for immune-checkpoint targeted therapy at ASCO 2015. Oncoimmunology 2016 ; 5 : e1068494. [CrossRef] [PubMed] [Google Scholar]
  2. Gandhi L Rodríguez-Abreu D Gadgeel S et al. Pembrolizumab plus chemotherapy in metastatic non-small-cell lung Cancer. N Engl J Med 2018. doi: 10.1056/NEJMoa1801005 [Google Scholar]
  3. Patel SA Minn AJ Combination cancer therapy with immune checkpoint blockade: mechanisms and strategies. Immunity 2018 ; 48 : 417–433. [CrossRef] [PubMed] [Google Scholar]
  4. Rothschild D Weissbrod O Barkan E et al. Environment dominates over host genetics in shaping human gut microbiota. Nature 2018 ; 555 : 210–215. [CrossRef] [PubMed] [Google Scholar]
  5. Routy B Le Chatelier E Derosa L et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science 2018 ; 359 : 91–97. [CrossRef] [PubMed] [Google Scholar]
  6. Derosa L, Hellmann MD, Spaziano M, et al. Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small cell lung cancer. Ann Oncol 2018; Mar 30. doi: 10.1093/annonc/mdy103. [Google Scholar]
  7. Shono Y, Docampo MD, Peled JU, et al. Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice. Sci Transl Med 2016; 8 : 339ra71. [CrossRef] [PubMed] [Google Scholar]
  8. Vétizou M Pitt JM Daillère R et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science 2015 ; 350 : 1079–1084. [CrossRef] [PubMed] [Google Scholar]
  9. Sivan A Corrales L Hubert N et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science 2015 ; 350 : 1084–1089. [CrossRef] [PubMed] [Google Scholar]
  10. Gopalakrishnan V Spencer CN Nezi L et al. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science 2018 ; 359 : 97–103. [CrossRef] [PubMed] [Google Scholar]
  11. Matson V Fessler J Bao R et al. The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients. Science 2018 ; 359 : 104–108. [CrossRef] [PubMed] [Google Scholar]
  12. Lagier JC Raoult D Greffe de microbiote fécal et infections : mise au point, perspectives. Med Sci (Paris) 2016 ; 32 : 991–997. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  13. Anhê FF Nachbar RT Varin TV et al. A polyphenol-rich cranberry extract reverses insulin resistance and hepatic steatosis independently of body weight loss. Mol Metab 2017 ; 6 : 1563–1573. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.